Overview
Basic Stats
The share price of Imperial Brands PLC - Depositary Receipt (Common Stock) as of June 10, 2024 is $25.35 / share.
The Factor Analysis chart (below right) shows a view of Imperial Brands PLC - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
Market Cap | |
EV | |
Shares Out. | 835.20 MM |
Earnings Date | |
EPS (TTM) | 3.08 |
Dividend Yield | |
Ex-Dividend Date | 2025-08-22 |
Borrow Rate | 0.36 |
Short Shares Avail. | 0.50 MM |
Short Interest | |
Short Float | |
Days to Cover | |
Risk Free Rate | 4.17 % |
Price Change (1 yr) | |
Volatility (1 yr) | |
Beta | |
Sharpe Ratio (1 yr) | |
Sortino Ratio (1 yr) |
PE Ratio | |
Price/Book | |
Price/TBV | |
Book/Market | |
EBIT/EV | |
EBIT(3yr avg)/EV | |
ROA | 0.09 |
ROE | 0.43 |
ROIC | 0.16 |
CROIC | -0.00 |
OCROIC | 0.20 |
Implied Volatility | |
Put/Call OI Ratio |
Growth | |
Profitability | |
Quality Score | |
Value Score | |
Momentum Score | |
Stability (Low Vol) Score | |
Analyst Sentiment | |
Fund Sentiment | |
Insider Sentiment | |
Officer Sentiment | |
Dividend Score | |
QVM Score | |
Piotroski F-SCORE |
Price Target
The average one-year price target for Imperial Brands PLC - Depositary Receipt (Common Stock) is $45.04. The forecasts range from a low of $32.76 to a high of $55.34. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Imperial Brands PLC - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2024-05-21 | Deutsche | Buy | Reiterate | |
2024-04-22 | Jefferies | Hold | Reiterate | |
2023-11-20 | JP Morgan Cazenove | Overweight | Reiterate | |
2023-09-28 | JP Morgan Cazenove | Overweight | Reiterate | |
2023-09-26 | Barclays | Overweight | Reiterate | |
2023-07-11 | Jefferies | Hold | Reiterate | |
2023-06-26 | Jefferies | Hold | Reiterate | |
2023-05-17 | Barclays | Overweight | Reiterate | |
2023-04-12 | Jefferies | Hold | Reiterate | |
2022-11-25 | Deutsche | Buy | Reiterate | |
2022-11-22 | RBC Capital Markets | Outperform | Reiterate | |
2022-11-18 | RBC Capital Markets | Overweight | Reiterate | |
2022-11-16 | Deutsche | Buy | Reiterate | |
2022-11-11 | Citigroup | Neutral | Reiterate | |
2022-10-10 | JP Morgan Cazenove | Overweight | Reiterate | |
2022-10-07 | Deutsche | Buy | Reiterate | |
2022-10-07 | Barclays | Overweight | Reiterate | |
2022-06-01 | RBC Capital Markets | Outperform | Reiterate | |
2022-05-18 | JP Morgan Cazenove | Overweight | Reiterate | |
2022-05-17 | Deutsche | Buy | Reiterate | |
2022-05-17 | Barclays | Overweight | Reiterate | |
2022-05-11 | Morgan Stanley | Equal Weight | Reiterate | |
2022-05-06 | Barclays | Overweight | Reiterate | |
2022-04-24 | Morgan Stanley | Equal Weight | Reiterate | |
2022-04-11 | JP Morgan Cazenove | Overweight | Reiterate | |
2022-04-07 | Deutsche | Buy | Reiterate | |
2022-04-06 | Barclays | Overweight | Reiterate | |
2022-04-01 | RBC Capital Markets | Outperform | Reiterate | |
2022-03-28 | JP Morgan Cazenove | Overweight | Reiterate | |
2022-03-25 | Morgan Stanley | Equal Weight | Reiterate | |
2022-03-09 | Morgan Stanley | Equal Weight | Reiterate | |
2022-03-08 | Barclays | Overweight | Reiterate | |
2022-02-08 | Deutsche | Reiteration | Reiterate | |
2022-01-25 | Deutsche | Reiteration | Reiterate | |
2021-11-19 | JP Morgan Cazenove | Reiteration | Reiterate | |
2021-11-17 | Deutsche | Reiteration | Reiterate | |
2021-11-17 | Deutsche Bank | Buy | Reiterate | |
2021-11-16 | Barclays | Reiteration | Reiterate | |
2021-11-15 | Morgan Stanley | Reiteration | Reiterate | |
2021-10-19 | Deutsche Bank | Buy | Reiterate | |
2021-10-07 | Barclays | Overweight | Reiterate | |
2021-06-28 | Barclays | Overweight | Reiterate | |
2021-05-19 | Deutsche Bank | Buy | Reiterate | |
2021-05-19 | Jefferies | Hold | Reiterate | |
2021-05-14 | Barclays | Overweight | Reiterate | |
2021-01-28 | Jefferies | Buy | Reiterate | |
2021-01-21 | RBC Capital Markets | Outperform | Reiterate | |
2021-01-14 | Barclays | Overweight | Reiterate | |
2020-11-19 | JP Morgan Cazenove | Overweight | Reiterate | |
2020-09-02 | Morgan Stanley | Underweight | Reiterate | |
2020-06-03 | JP Morgan Cazenove | Neutral | Reiterate | |
2020-05-20 | Liberum Capital | Buy | Reiterate | |
2020-05-20 | Citigroup | Buy | Reiterate | |
2020-01-30 | Jefferies | Buy | Reiterate | |
2019-10-28 | RBC Capital Markets | Underperform | Reiterate | |
2019-10-24 | Liberum Capital | Buy | Reiterate | |
2019-10-10 | UBS | Neutral | Reiterate | |
2019-09-27 | Liberum Capital | Buy | Reiterate | |
2019-08-28 | Liberum Capital | Buy | Reiterate | |
2019-07-09 | Deutsche Bank | Buy | Reiterate | |
2019-06-16 | Morgan Stanley | Underweight | Reiterate | |
2019-05-07 | JP Morgan Cazenove | Neutral | Reiterate | |
2019-05-01 | Jefferies | Buy | Reiterate | |
2019-05-01 | Credit Suisse | Outperform | Reiterate | |
2019-05-01 | Deutsche Bank | Buy | Reiterate | |
2019-02-22 | Citigroup | Neutral | Reiterate | |
2019-02-22 | Deutsche Bank | Buy | Reiterate | |
2018-11-29 | Jefferies | Buy | Reiterate | |
2018-11-09 | Barclays | Overweight | Reiterate | |
2018-11-07 | RBC Capital Markets | Underperform | Reiterate | |
2018-11-07 | Deutsche Bank | Buy | Reiterate | |
2018-11-07 | JP Morgan Cazenove | Neutral | Reiterate | |
2018-10-09 | Deutsche Bank | Buy | Reiterate | |
2018-09-19 | Barclays | Overweight | Reiterate | |
2018-07-03 | Berenberg Bank | Buy | Reiterate | |
2018-06-20 | Liberum Capital | Buy | Initiate | |
2018-06-12 | Barclays | Overweight | Reiterate | |
2018-05-11 | Berenberg Bank | Buy | Reiterate | |
2018-05-09 | RBC Capital Markets | Outperform | Reiterate | |
2018-05-09 | Credit Suisse | Outperform | Reiterate | |
2018-05-03 | Citigroup | Neutral | Reiterate | |
2018-04-17 | JP Morgan Cazenove | Neutral | Reiterate | |
2018-03-23 | Deutsche Bank | Buy | Reiterate | |
2018-03-16 | Berenberg Bank | Buy | Reiterate | |
2017-11-29 | Citigroup | Neutral | Reiterate | |
2017-11-17 | Jefferies | Buy | Reiterate | |
2017-11-07 | JP Morgan Cazenove | Neutral | Reiterate | |
2017-10-12 | Deutsche Bank | Buy | Reiterate | |
2017-10-02 | Jefferies | Buy | Reiterate | |
2017-09-20 | Goldman Sachs | Buy | Reiterate | |
2017-09-11 | Credit Suisse | Outperform | Reiterate | |
2017-09-06 | Jefferies | Buy | Reiterate | |
2017-06-30 | Berenberg Bank | Buy | Reiterate | |
2017-06-29 | Goldman Sachs | Buy | Reiterate | |
2017-06-28 | Citigroup | Neutral | Reiterate | |
2017-06-22 | JP Morgan Cazenove | Neutral | Reiterate | |
2017-05-23 | Berenberg Bank | Buy | Reiterate | |
2017-05-22 | Jefferies | Buy | Reiterate | |
2017-05-04 | Deutsche Bank | Buy | Reiterate | |
2017-05-04 | Goldman Sachs | Buy | Reiterate | |
2017-04-27 | Citigroup | Neutral | Reiterate | |
2017-03-27 | Barclays | Overweight | Reiterate | |
2017-01-23 | Barclays | Overweight | Reiterate | |
2017-01-16 | Jefferies | Buy | Reiterate | |
2017-01-11 | Goldman Sachs | Buy | Reiterate | |
2017-01-04 | Berenberg Bank | Buy | Reiterate | |
2016-12-07 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-12-02 | Goldman Sachs | Buy | Reiterate | |
2016-11-16 | Deutsche Bank | Buy | Reiterate | |
2016-11-15 | Jefferies | Buy | Reiterate | |
2016-11-11 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-11-10 | Berenberg Bank | Buy | Reiterate | |
2016-10-28 | Deutsche Bank | Buy | Reiterate | |
2016-10-17 | Credit Suisse | Neutral | Reiterate | |
2016-10-11 | Jefferies | Buy | Reiterate | |
2016-09-30 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-09-29 | Credit Suisse | Neutral | Reiterate | |
2016-09-21 | Jefferies | Buy | Reiterate | |
2016-09-09 | Deutsche Bank | Buy | Reiterate | |
2016-08-24 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-08-02 | Societe Generale | Buy | Reiterate | |
2016-07-06 | Berenberg Bank | Buy | Reiterate | |
2016-07-05 | UBS | Buy | Reiterate | |
2016-07-04 | Credit Suisse | Outperform | Reiterate | |
2016-06-29 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-06-27 | Exane BNP Paribas | Outperform | Reiterate | |
2016-06-17 | RBC Capital | Underperform | Sector Perform | Upgrade |
2016-06-14 | UBS | Buy | Reiterate | |
2016-06-10 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-06-09 | Citigroup | Buy | Reiterate | |
2016-06-09 | Credit Suisse | Outperform | Reiterate | |
2016-06-01 | Societe Generale | Buy | Reiterate | |
2016-05-20 | Goldman Sachs | Buy | Reiterate | |
2016-05-09 | Goldman Sachs | Buy | Reiterate | |
2016-05-06 | Berenberg Bank | Buy | Reiterate | |
2016-05-05 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-05-04 | Credit Suisse | Outperform | Reiterate | |
2016-04-29 | Citigroup | Buy | Reiterate | |
2016-04-25 | Goldman Sachs | Buy | Reiterate | |
2016-04-19 | JP Morgan Cazenove | Neutral | Reiterate | |
2016-04-08 | Credit Suisse | Outperform | Reiterate | |
2016-04-05 | Goldman Sachs | Neutral | Reiterate | |
2016-03-30 | Nomura | Reduce | Reiterate | |
2016-03-18 | Exane BNP Paribas | Outperform | Reiterate | |
2016-03-10 | Citigroup | Buy | Reiterate | |
2016-02-25 | Nomura | Reduce | Reiterate | |
2016-02-16 | Credit Suisse | Outperform | Reiterate | |
2016-02-12 | Societe Generale | Buy | Reiterate | |
2016-02-12 | Citigroup | Buy | Reiterate | |
2016-02-11 | UBS | Buy | Reiterate |